North America Scar Treatment Market To Witness Rapid Growth With Janssen Biotech, Inc. Completing Acquisition Of Bermekimab, An Anti-IL-1alpha Monoclonal Antibody, From Xbiotech
A scar is an area of fibrous tissue that replaces normal skin after an injury. Some scars are barely visible, while others may cause pain, restrict movement or affect sleep. Whether scars result from trauma, surgery, acne, or any other causes, treatments are out there to diminish their impact. There are even different kinds of scars, which depend on the underlying cause and appearance of the scars, so proper treatment must be sought and considered. Increasing incidents of burns and acne cases are expected to drive the growth of the North America scar treatment market . According to the Centers for Disease Control Prevention (CDC), around 1.1 million burn injuries in the U.S. require medical attention, while 4,500 of these people die each year. Furthermore, around 10,000 people in the U.S. die every year of burn-related infections. According to the American Academy of Dermatology Association (AADA), around 85% of people between ages 12 to 24 experience at least minor acne, affec...